Metraipolis › archive › dc_5d3cec995aba

Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial — Europe PMC PMID:41287157

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41287157
DOI
10.1111/acem.70191
License (as archived)
solo-consultazione
Archived
2026-11-08T07:54:21.869Z
SHA-256 of the archived text
e6660bd43d3be8d8a42701f9110e56f9b77dd541ce6b1c44f4b9a48f4121fef2
Stable URL of this page
https://metraipolis.com/documento/dc_5d3cec995aba

How to cite

Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial — Europe PMC PMID:41287157 — Europe PMC (en), https://europepmc.org/article/MED/41287157 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d3cec995aba (Metraipolis archive dc_5d3cec995aba, sha256 e6660bd43d3be8d8a42701f9110e56f9b77dd541ce6b1c44f4b9a48f4121fef2)
BibTeX
@misc{dc5d3cec995aba,
  title = {Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial — Europe PMC PMID:41287157},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41287157},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d3cec995aba; sha256 e6660bd43d3be8d8a42701f9110e56f9b77dd541ce6b1c44f4b9a48f4121fef2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41287157. Agents can read the archived copy with the MCP tool read_document.